Jakafi User Reviews & Ratings (Page 2)
Jakafi has an average rating of 7.4 out of 10 from a total of 30 reviews on Drugs.com. 68% of reviewers reported a positive experience, while 16% reported a negative experience.
Reviews for Jakafi
- Kurt
- Taken for 1 to 2 years
- September 7, 2023
For Graft-versus-host disease "Taking Jakafi for 1 year 3 months, working well with no side effects. Take 5 mg daily. I take it for GvHD of the skin, and it has done a great job controlling it. I have had no flare-ups."
- Kelly
- Taken for 1 to 2 years
- April 27, 2019
For Polycythemia Vera "It works, feel fine!"
Frequently asked questions
- What are JAK inhibitors and how do they work?
- Which JAK inhibitors are approved in the U.S?
- What are the most common skin conditions? (with photos)
- Jan
- Taken for 2 to 5 years
- May 21, 2023
For Polycythemia Vera "I have benefited from Jakafi maintaining my platelet count. I have experienced UTI and not sure Jakafi caused it. I also experience gas and diarrhea."
- Just...
- Taken for 1 to 2 years
- November 26, 2023
For Polycythemia Vera "It has worked very well for me. However, I have gained quite a bit of weight since taking it."
Are you taking this medicine?
- Micker
- Taken for 1 to 6 months
- August 12, 2023
For Myelofibrosis "No side effects, on 5 mg, twice a day, raised my hemoglobin levels, decreased my tiredness."
- Srwal...
- March 20, 2023
For Graft-versus-host disease "My platelets were affected but so far my liver GVHD has improved."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Jakafi (ruxolitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (32)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
"It's brought my platelets right down, but lately my stomach has been killing me after I eat. Not sure if it's the Jakafi that's causing it."